by University of Michigan Working in the Chinnaiyan Lab. Credit: University of Michigan Rogel Cancer Center It’s a scientific riddle tangled up in a complex web. How do you turn an immune cold cancer into one that responds to immunotherapy? Researchers led by the University of Michigan Rogel Cancer Center started with a simple thread: an...
KANAZAWA UNIVERSITY IMAGE: SUCLA2 GENE IS FREQUENTLY INVOLVED IN THE DELETION OF RB1 GENE REGION, WHICH OCCURS IN 10 – 30 % OF ADVANCED PROSTATE CANCERS. SUCLA2 DELETION GIVES RISE TO A METABOLIC. Kanazawa, Japan – The compound thymoquinone (TQ) selectively kills prostate cancer cells at advanced stages, according to a new study published in Oncogene....
